Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F13MR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,397
Award facts
- Contract value 100% obligated
- $12,397.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 6, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $12,397.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This non-set-aside, firm fixed-price contract represents a single delivery order with an ultimate completion date of January 7, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $1 billion through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement. The company's extensive portfolio of federal contracts demonstrates its capability to deliver brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Department of Defense, Defense Health Agency, and other federal healthcare systems. As a competitively awarded contractor with no set-aside designation, AmerisourceBergen Drug Corp continues to fulfill federal pharmaceutical supply requirements through open competition alongside other qualified vendors under the DLA's comprehensive medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F13MR?
SPE2DR26F13MR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F13MR worth?
The government has obligated $12,397 on SPE2DR26F13MR.
Is contract SPE2DR26F13MR an order under another contract?
Yes. SPE2DR26F13MR is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13MR competed?
The extent of competition for SPE2DR26F13MR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award